Monoamine Contributions to Neurocircuitry in Eating Disorders



Status:Completed
Conditions:Psychiatric, Eating Disorder
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 45
Updated:5/19/2016
Start Date:May 2011
End Date:April 2016

Use our guide to learn which trials are right for you!

This study will use brain imaging technologies to measure several neurotransmitters
(serotonin and dopamine) that contribute to our abilities to respond to reward or inhibit
our impulses, and which are known to be altered in the brain of people with anorexia nervosa
(AN) and bulimia nervosa (BN). Because palatable food stimulates dopamine secretion, we
propose to use a challenge with brain imaging that will stimulate dopamine release which we
hypothesize will generate anxiety rather than pleasure in AN, and will help explain why AN
restrict eating in order to reduce anxiety. This study will help to understand the unique
puzzling symptoms in eating disorders and contribute to finding better methods for
identifying effective treatments for these often relapsing and sometimes chronic disorders.

Alterations of serotonin (5-HT) and dopamine (DA) activity may contribute to extremes of
appetitive behaviours in anorexia nervosa (AN) and bulimia nervosa (BN), through effects on
inhibitory and reward neural pathways. To avoid the confounding effects of malnutrition, and
because they have behaviours and neural circuit alterations relevant for this study, we will
study 25 recovered (REC) restricting-type AN, 25 REC bulimic-type AN (AN-BN), 25 REC BN, and
25 control women (CW). This 5 year study, of women 18 to 45 years old, will employ positron
emission tomography (PET) imaging with radioligands for the 5-HT transporter ([11C]DASB) and
DA D2/D3 receptors ([11C]raclopride).

Inclusion

- history of DSM-IV diagnosis of anorexia or bulimia.

- AN women have history of ABW below 85% for height.

- AN-BN subjects have history of ABW below 85% ABW.

- AN-BN subjects have history of binging/purging behaviors during a period of low
weight.

- Subjects must be right-handed.

- Subjects have been recovered for 12 months or more.

Exclusion

- Diagnosis of alcohol or drug abuse or dependence in the 3 months.

- Alcohol or substance use within 30 days.

- Current diagnosis of an Axis I disorder.

- Organic brain syndromes, dementia, psychotic disorders, or mental retardation.

- Neurological or medical disorders such as seizure disorder, renal disease, diabetes,
thyroid disease, EKG indicative of electrolyte imbalance

- BN subjects whose purging methods were the use of laxatives, diuretics

- Use of psychoactive medication in the 3 months.

- Pregnancy or lactation.

- Tobacco use in the 3 months.
We found this trial at
1
site
San Diego, California 92093
Phone: 858-534-8031
?
mi
from
San Diego, CA
Click here to add this to my saved trials